Strüngmann Brothers invest in eHealth Specialist ICW

InterComponentWare AG (ICW)Santo Holding (Germany) GmbH of Hexal founders Strüngmann secured a 25 percent share in the eHealth specialist InterComponentWare AG (ICW). This transaction was performed by the purchase of newly issued shares in the context of an increase in capital stock. The present owners of ICW do not surrender any shares in this transaction.

ICW will invest its newly acquired funds into the further expansion of its leading position in the international eHealth market. The company is one of the internationally active eHealth pioneers and offers a very broad range of solutions focusing on citizens respectively patients.

ICW pursues two strategic approaches to improve communication and thus also quality and efficiency in the health care system: First of all, it supports the introduction of ubiquitous secure health care IT infrastructures with electronic health cards and personal health records. At the beginning of 2007, ICW was awarded the pilot project for the introduction of the national electronic health card in Bulgaria. The company also conducts a field test for the electronic health card in Germany since 2005, which includes the personal health record LifeSensor. The LifeSensor technology is also applied in the BARMER research project, in which Germany's largest health insurance company will offer its approx. 7 million insurants a personal health record.

ICW's second strategic approach is to network medical professionals in medical practices and hospitals with each other. PPV, for example, a Bavarian physician's network, uses ICW solutions to give its approximately 350 members a comprehensive view of their patients' medical data. Heidelberg University Hospital also opted for a solution developed by ICW to network with its partner hospitals. This solution also incorporates patients and resident physicians into the improved data flow.

"The trust of our new investors in ICW shows that we are pursuing the right strategy and that our solutions have a large national and international market potential", explains ICW's CEO Peter Reuschel. The Strüngmann brothers are also absolutely convinced that ICW will continue to expand its position in the global eHealth market: "We opted for an investment in ICW, because it is in a perfect position to assert itself in the high-growth global eHealth market with its open platform approach and mature solutions. With its networking solutions, ICW has the potential to make the national and global health care market more efficient. We want to support and accompany this process", explain the Strüngmann brothers.

Related news articles:

About InterComponentWare
InterComponentWare AG (ICW) is a leading international eHealth specialist with locations in Germany, the United States, Austria, Switzerland and Bulgaria. Its solutions for networking the various players in the healthcare system lastingly improve process-oriented communication and data integrity, and therefore also the quality of healthcare. Among other things, ICW develops and distributes software and hardware components for the healthcare IT infrastructure for electronic health cards, the LifeSensor personal health record as well as networking solutions for hospitals and physician offices. As part of the bIT4health consortium, ICW provided important consulting services for the implementation of the electronic health card in Germany, is involved in the Austrian eCard project and has won the pilot project for the national health card in Bulgaria. For further information, visit:

Most Popular Now

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...